bilaterals.org logo
bilaterals.org logo

intellectual property

India in free trade talks with four European countries
14-Feb-2007 Navhind Times
India is in talks with four European countries - Switzerland, Norway, Iceland and Liechtenstein - to strike a comprehensive economic agreement that would facilitate free trade relations. Switzerland is also trying to set up a working group with India on intellectual property rights and also seeking to enhance cooperation in science and technology fields.
Not under the same sky: bilateral free trade agreements (FTAs), agriculture and food sovereignty
12-Feb-2007 PANAP
An initial report on the spread of Free Trade Agreements (FTAs) throughout the Asia-Pacific and their impacts on agriculture and food sovereignty, in the context of the current state of play of the WTO, and the devastating legacy of agricultural liberalisation through World Bank/International Monetary Fund structural adjustment programmes.
Activists want waste provisions to be removed from agreement
12-Feb-2007 Bangkok Post
Activists have called on Thailand’s National Legislative Assembly to remove trade in waste and micro-organism patenting from the Japan-Thailand Free Trade Agreement (FTA).
Intellectual property, bilateral agreements and sustainable development: The challenges of implementation
6-Feb-2007 CIEL
What appears to be the experience of countries that have negotiated FTAs is that the process of negotiations does not conclude with the signing of the agreement. The implementation process is a complex and tedious one. In addition, once this implementation phase has been concluded, a subsequent and difficult phase begins with the monitoring of this implementation.
Japan-Thailand FTA (JTEPA): draft chapter on intellectual property
3-Feb-2007
Japan resurfaces global IPR enforcement framework; EU refers to FTAs
1-Feb-2007 IP Watch
The EU is planning a more detailed intellectual property chapter in its FTAs. In form, not in content, it would be closer to the “US-type” with “detailed things” listed.
Thai Human Rights Commission criticises FTA with US
27-Jan-2007
In what is believed to be the first ever human rights impact assessment of a US FTA conducted at national level, the National Human Rights Commission of Thailand in a draft report concludes that the FTA that Thailand has been negotiating with the United States will violate the human rights of Thai people and affect the country’s sovereignty.
US and India sign historic MoU on bilateral cooperation on IP
22-Dec-2006 ag-IP-news
The Department of Commerce’s United States Patent and Trademark Office (USPTO) announced on Thursday that Under-Secretary of Commerce for Intellectual Property Jon Dudas and Ajay Dua, secretary of the Indian Ministry of Commerce and Industry (IMCI), recently signed a historic Memorandum of Understanding (MoU) on Bilateral Cooperation between the United States and India on intellectual property issues.
Harmonisation of TRIPS-plus IPR policies and potential impacts on technological capability: A case study of the pharmaceutical industry in Thailand
14-Dec-2006 ICTSD
This study examines the impacts of TRIPS-plus rules on pharmaceutical patents as enshrined in US FTAs by looking at the case of Thailand.
US advises developing country FTA partners not to follow WHO IP plan
12-Dec-2006 IP Watch
Developing countries that have free trade agreements (FTAs) with the United States received an email in the form of a “démarche” from the US government before the 4-8 December 2006 meeting of the WHO Intergovernmental Working Group on Public Health, Innovation and Intellectual Property Rights saying that it had become apparent that the WHO was trying to go beyond its competency and address issues which could have impact on the scope and effect of FTAs.
EU ’strongly committed’ to Mediterranean agriculture
8-Dec-2006 Food Navigator
The EU has sought to ease frustrations that agricultural trade within the Mediterranean region has not advanced as quickly as hoped.
US-India MoU on IPR (2006)
6-Dec-2006
The new ’Global Europe’ strategy of the EU: Serving corporations worldwide and at home
3-Dec-2006
Alert to European civil society groups, trade unions and social movements from the Seattle to Brussels Network
US-Russia bilateral/WTO deal pushes new standards for IP protection
26-Nov-2006 IP Watch
In its bilateral negotiation with the United States in order to join the World Trade Organization, Russia appears to have agreed to intellectual property rights standards that push those of the WTO and US law to new levels.
Draft EU-Caribbean EPA - IPR non-paper (Nov 2006)
17-Nov-2006 IP Watch
Dominican trade agreement with US contemplates extending patents by 3 years
31-Oct-2006 Dominican Today
Legislation proposed for implementing the Free Trade Agreement with Central America and the United States (DR-CAFTA), presented to the Congress by the central government, contemplates a three-year extension beyond the 20 currently in force, for invention patents protection established in the Industrial Property law 20-00.
IP developments in the DR-CAFTA countries
26-Oct-2006 Mondaq
Current state of play with intellectual property law reforms in Central America under the US-DR-CAFTA.
Korea demands recognition for generic drugs
19-Oct-2006 Korea Times
A Korea-US Free Trade Agreement (FTA) for pharmaceuticals is likely to speed up in the fourth round of the FTA talks, which will begin place Monday on Cheju Island.
Data exclusivity regulations in India
18-Oct-2006
New Indian data exclusivity patenting regulations will severely hinder generic AIDS drugs manufacturing in India, and thus less people will have access to AIDS therapy globally. The world’s poor overwhelmingly make up this population with lack of access. Because of this, moral human rights and distributive justice approaches should compel India to take an equity-oriented approach in access to AIDS medicines and reject data exclusivity regulations currently under discussion.
US FTA may cost drug industry $1.2 billion: gov’t
17-Oct-2006 Hankyoreh
A proposed free trade agreement with the United States is expected to cost as much as 1 trillion won (US$1.2 billion) in damage to the South Korean pharmaceutical industry if the US proposal for the deal is accepted, the South Korean government said.